Home › Funds › Point72 Asset Management › FENC
Point72 Asset Management position in FENC
FENNEC PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)56.41K sh
Reported value held$606.38K
Portfolio Weight0.00%
First reportedQ1 2023
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2023 | 3.10K | $25.79K | New |
| Q4 2025 | 21.30K | $164.00K | New |
| Q2 2026 | 56.41K | $606.38K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding FENC
- BlackRock Inc 1.73M sh · $18.57M · Q2 2026
- Vanguard Group 1.07M sh · $8.22M · Q4 2025
- Geode Capital Management 402.57K sh · $4.33M · Q2 2026
- Morgan Stanley 221.92K sh · $2.39M · Q2 2026
- Northern Trust Corp 167.92K sh · $1.81M · Q2 2026
- Marshall Wace 138.76K sh · $1.49M · Q2 2026
- Renaissance Technologies 134.20K sh · $1.44M · Q2 2026
- AQR Capital Management 92.89K sh · $998.56K · Q2 2026
- Wellington Management Group 84.55K sh · $908.89K · Q2 2026
- Citadel Advisors 71.03K sh · $763.59K · Q2 2026
- Charles Schwab Investment Management 70.50K sh · $757.92K · Q2 2026
- BNY Mellon 61.03K sh · $656.10K · Q2 2026